3 Patents
- US125393032026RET Inhibitor for Use in Treating Cancer Having a RET Alteration
Rigel Pharmaceuticals, Inc.
0 cites - US119639582024RET Inhibitor for Use in Treating Cancer Having a RET Alteration
Rigel Pharmaceuticals, Inc.
0 cites - US118721922024RET Inhibitor for Use in Treating Cancer Having a RET Alteration
BLUEPRINT MEDICINES CORPORATION
0 cites